Ocugen is trading at $1.42 (5.3% down) amid continued volatility following its $115 million convertible notes deal and wider Q1 losses, which previously triggered a sharp selloff.
- The downward move is attributed to lingering investor caution and profit-taking following recent price swings related to the May 2026 debt offering.
- The decline appears company-specific as major indices are trading modestly higher today, indicating the selloff is decoupled from broader market trends.